[Editorial commentary]

[Article in Hungarian]

[Article in Hungarian]

Péter Igaz. Orv Hetil. 2011.

. 2011 Mar 6;152(10):365.

doi: 10.1556/OH.2011.29051.

No abstract available

Similar articles

Neuroendocrine tumors: recent progress in diagnosis and treatment.
Oberg K. Oberg K. Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:E3-6. doi: 10.1530/ERC-10-0288. Print 2011 Oct. Endocr Relat Cancer. 2011. PMID: 22005111 No abstract available.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers.
O'Toole D, Grossman A, Gross D, Delle Fave G, Barkmanova J, O'Connor J, Pape UF, Plöckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society. O'Toole D, et al. Neuroendocrinology. 2009;90(2):194-202. doi: 10.1159/000225948. Epub 2009 Aug 28. Neuroendocrinology. 2009. PMID: 19713711 No abstract available.
Future perspectives on neuroendocrine tumors.
Castellano D, Salazar R, Raymond E. Castellano D, et al. Cancer Metastasis Rev. 2011 Mar;30 Suppl 1:35-40. doi: 10.1007/s10555-011-9294-z. Cancer Metastasis Rev. 2011. PMID: 21327890 Review.
[Delay in the introduction of treatment modalities for neuroendocrine tumors in Japan].
Imamura M. Imamura M. Gan To Kagaku Ryoho. 2013 Jul;40(7):847-50. Gan To Kagaku Ryoho. 2013. PMID: 23863725 Japanese.
Guest editorial. Special issue on neuroendocrine tumors.
Yamashita S. Yamashita S. Pituitary. 2006;9(3):163-4. doi: 10.1007/s11102-006-0389-4. Pituitary. 2006. PMID: 17036193 No abstract available.